Resources
Case Study
Driving Genetic Testing and Patient Identification in an Ultra-Rare Disease
View Case Studies ›
RMN delivers structured rare disease education to specialists — then shows you how each physician engaged with it, stage by stage, with Physician Level Data Plus.
Pharma marketers need rare disease specialists to diagnose patients. These specialists see the condition once or twice in a career. Standard HCP programs measure whether a physician saw an ad. Nobody tracks how physicians engage with the education that gets them there. That gap — between reached and ready — is where patients get lost.
“I’ve never heard of this” — Physician learns the condition exists. Huge in rare disease where they may see it once in a career.
“I might have seen this” — Physician can recognize symptoms and connect them to the condition.
“I know how to confirm this” — Physician knows the diagnostic pathway, tests to order, specialists to refer to.
“I’m ready to prescribe” — Physician understands the therapy and is confident initiating treatment.
Most pharma marketing starts at stage 4. But if a physician can’t identify the patient, treatment messaging lands on deaf ears.
Every vendor reports who saw it. We show you how they engaged with it.
Standard Physician Level Data shows surface metrics — clicks, views, time on page. PLD+ captures which education stages each physician has engaged with — from disease awareness content through treatment material. That’s not a media metric. That’s an engagement profile.
Each content format serves a different educational purpose. Five Facts and Spotlights build disease awareness. Rare Views make complex clinical information visual. Rare IQs test clinical knowledge. Rare Mysteries challenge diagnostic reasoning. Each interaction generates PLD+ data.
View Framework ›See how RMN’s methodology and PLD+ data can transform your rare disease HCP strategy.